Pancreatitis in adult with acute lymphoblastic leukemia using L-asparaginase and simvastatin: case report and systematic review
DOI:
https://doi.org/10.11606/issn.2176-7262.v49i1p90-94Palabras clave:
Precursor Cell Lymphoblastic Leukemia-Lymphoma. Asparaginase. Pancreatitis. Simvastatin. Drug InteractionResumen
Context: Acute pancreatitis is a inflammatory process of the pancreas. It can be caused by gallstones, metabolic disorders, associated or not with alcohol abuse, or medication. Case Report: A 38-year-old man was admitted to the hospital because of worsening of nausea, abdominal pain, dizziness and white stool. Patient was diagnosed with severe acute pancreatitis. After six days of hospitalization, patient progressed into hypotension and severe bradycardia, and died. The patient used simvastatin chronically, and was in treat with L-asparaginase, both drugs related to the occurence of acute pancreatitis separately. Naranjo´s probability scale of adverse drug reaction established the causality between these medications and acute pancreatitis as probable. However, due to the absence of reports of causality, the acute pancreatitis is associated with to the use of L-asparaginase with possible drug interactions with simvastatin. Conclusion: It is very important to monitor patients treated with L-asparaginase, through careful observation of clinical signs and laboratory follow-up, as well as verification of other medications in use. The AP may have different levels of severity, being indispensable the quick diagnosis and early treatmentDescargas
Los datos de descarga aún no están disponibles.
Descargas
Publicado
2016-02-02
Número
Sección
Relato de Caso
Licencia
Cómo citar
1.
Rodrigues R, Gavarrete DD, Bernardi Érika AT, Munhoz EC. Pancreatitis in adult with acute lymphoblastic leukemia using L-asparaginase and simvastatin: case report and systematic review. Medicina (Ribeirão Preto) [Internet]. 2016 Feb. 2 [cited 2024 Dec. 21];49(1):90-4. Available from: https://revistas.usp.br/rmrp/article/view/118379